{
    "nct_id": "NCT06295588",
    "official_title": "Minimizing Fatigue and Inflammation in Survivors of Cancer: A Pilot Randomized Clinical Trial of the Seaweed Supplement Fucoidan",
    "inclusion_criteria": "* Survivors of cancer\n* Age 18 or older\n* Speak and understand English\n* Have completed surgery, radiation, and/or systemic intravenous anticancer therapy (e.g., chemotherapy, targeted therapy, immunotherapy) â‰¤10 years prior to enrollment.\n* Have a baseline level of fatigue, as determined by reporting a score of 4 or higher for the question, \"In the last week, how bad was your worst fatigue on a scale from 0-10?\"\n* Be willing to commit to the fucoidan supplement dosing and delivery method, to complete evaluation instruments, and to attend all study visits.\n* Completed Informed Consent\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Current warfarin or other anti-coagulation medication use.\n* Current use of supplements that contain fucoidan\n* Any allergy to fucoidan\n* Be diagnosed with a major psychiatric illness requiring hospitalization within the last year.\n* Be diagnosed with dementia.\n* Be pregnant or nursing",
    "miscellaneous_criteria": ""
}